GDPR Considerations for DtP Supply Chains
Regulatory, Supply Chain
One of the primary challenges with Direct-to-Patient (DtP) supply chains is maintaining patient privacy. This is further complicated by the GDPR (General Data Protection Regulation), which is broadly designed to protect the right to personal data privacy for all EU citizens. The GCSG DTP Sub-team provides an overview of the key GDPR considerations and recommendations for organizations engaged in DtP.
Related Education Resources.
All Resources2018 GCSG US Conference Recap Video
Topic: Conference
Video
Members
GCSG sponsored study on INVESTIGATIVE SITE Receptivity to Direct-to-Patient Shipment in Clinical Trials
Topic: Direct-to-Patient
White Paper
Members
The Exponential Growth of Decentralized Trials, Direct-to-Patient and the Future of the Clinical Trials Landscape in Europe
Topics: Conference, Regulatory
Executive Summary
Members
